Skip to main content
ConductScienceScienceDex

Kyle Matthew Kampman

NIH Rank #2911
Unclaimed recordClaim profile
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1883848Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2025 award categories

  • Psychiatry

NIH Funding · FY2025

Linked Award Amount
$3.3M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#2,911
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Kyle Matthew Kampman. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Kyle Matthew Kampman as a PI. Multi-PI records show the full award amount for context.

  • 5UH3DA049694-04UH3
    Combining Pregabalin with Lofexidine: Can it Increase the Success of Transition to Naltrexone?
    University of Pennsylvania
    $2.6M
    award amount
  • 5R61DA061206-02R61
    Psilocybin: Capturing brain mechanisms of motivation and neurocognition in individuals with opioid use disorder
    University of Pennsylvania
    $472.1K
    award amount
  • 5R34DA057507-03R34
    Rapid outpatient low-dose initiation of buprenorphine for individuals with OUD using fentanyl
    University of Pennsylvania
    $230K
    award amount

Award organization

Organizations that administered FY2025 awards listing Kyle Matthew Kampman as a PI.

FY2025 award administered by University of Pennsylvania (PA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Pennsylvania
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    Entered Top 50% Nationally
    Ranked #829
  7. 2024
    Entered Top 25% Nationally
    Ranked #829
  8. 2024
    Entered Top 10% Nationally
    Ranked #829
  9. 2024
    Entered Top 5% Nationally
    Ranked #829

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Kyle Matthew Kampman.

Anna Rose Childress
University of Pennsylvania
3
shared awards
Ashish Prakash Thakrar
University of Pennsylvania
2
shared awards
George Edward Woody
University of Pennsylvania
2
shared awards
David S Mandell
University of Pennsylvania
1
shared award
Hillary R Bogner
University of Pennsylvania
1
shared award
Jesse Yenchih Hsu
University of Pennsylvania
1
shared award
John T Farrar
University of Pennsylvania
1
shared award
Laura M Dember
University of Pennsylvania
1
shared award

Explore further

Find collaborators for Kyle Matthew Kampman

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →